Respiratory Tract Cytopathology
Respiratory tract cytopathology is the cytologic study of cells exfoliated, brushed, washed, or aspirated from the airways and lung. It interprets sputum, bronchial brushings and washings, bronchoalveolar lavage fluid, and fine-needle aspirates to detect malignancy, characterise tumour type, and recognise infectious and benign reactive processes, providing a minimally invasive complement to histopathology in thoracic medicine.
Definition
Respiratory tract cytopathology is the branch of cytopathology concerned with the microscopic examination of individual cells and cell clusters obtained from the respiratory tract for the diagnosis of neoplastic, infectious, and reactive conditions.
Scope
This area orients the reader to the principal respiratory specimen types and what each can and cannot show. It groups topics on sputum cytology and lung-cancer detection, bronchial brushing and bronchoalveolar lavage, benign and infectious lesions, squamous cell carcinoma and adenocarcinoma, and small cell carcinoma and lymphoid processes. It is a reference and educational overview of how cytologic material from the respiratory tract is sampled and interpreted, not a manual for clinical decision-making.
Sub-topics
Core questions
- Which respiratory specimen type best samples a given lesion, and what are its diagnostic limits?
- How are malignant cells distinguished from reactive or reparative atypia in airway specimens?
- How is a cytologic diagnosis of lung cancer subtyped and integrated with ancillary and molecular testing?
Key concepts
- Exfoliative versus aspiration cytology
- Specimen adequacy and the alveolar-macrophage marker of lower-respiratory sampling
- Reactive and reparative atypia versus malignancy
- Cytomorphologic subtyping of lung carcinoma
- Immunocytochemistry and molecular testing on cytologic material
- Sensitivity-specificity trade-offs across specimen types
Clinical relevance
Cytologic specimens from the respiratory tract are often the first or only diagnostic material available in patients with suspected lung cancer, central airway lesions, or pulmonary infection, and modern cytology can frequently both establish malignancy and provide tissue for subtyping and molecular testing. This area describes how such material is generated and interpreted at a reference level; it does not provide diagnostic or treatment recommendations for individual patients.
Epidemiology
Lung cancer is among the leading causes of cancer death worldwide, and respiratory cytology contributes to its diagnosis across many clinical settings; the relative contribution of sputum, bronchoscopic, and aspiration specimens depends on tumour location and local practice (Rivera 2013; Schreiber 2003).
Evidence & guidelines
American College of Chest Physicians evidence-based guidance summarises the diagnostic performance of cytologic modalities for suspected lung cancer (Rivera 2013; Schreiber 2003), and the 2021 WHO classification of thoracic tumours frames how cytologic and histologic diagnoses are categorised and reported (Nicholson 2022).
History
Diagnostic respiratory cytology grew from early twentieth-century sputum examination into a structured discipline as bronchoscopy, fine-needle aspiration, and, later, immunocytochemistry and molecular assays expanded what cytologic specimens could deliver. The successive WHO classifications of lung tumours, most recently in 2021, progressively integrated cytologic criteria and biomarker-relevant categories (Nicholson 2022).
Related topics
Seminal works
- rivera-2013
- schreiber-2003
- nicholson-2022
Frequently asked questions
- What specimen types fall under respiratory tract cytopathology?
- Sputum, bronchial brushings and washings, bronchoalveolar lavage fluid, and fine-needle aspirates of pulmonary and mediastinal lesions are the principal cytologic specimens of the respiratory tract.
- How does respiratory cytology relate to histopathology?
- Cytology examines dispersed cells and small clusters rather than intact tissue architecture; it is typically less invasive and can establish or suggest a diagnosis, but architectural and some subtyping questions may still require a tissue biopsy.